Drug resistance has emerged to all antimalarial drugs. With resistance to the artemisinin-class drugs confirmed in 2008, there are now no available options for last-line-of-defense drugs should these new resistant genotypes spread worldwide. Dr. Boni will present some classic problems in drug-resistance management; demonstrate that some drug distribution methods may act to slow down resistance evolution; verify these results with individual-based microsimulations of malaria epidemics and drug-resistance evolution; and propose some changes to global malaria management strategy in different zones of malaria endemicity.
Last Updated On Thursday, April 25, 2019 by Crow, Sharon Weber
Created On Thursday, April 25, 2019
Click to enter calendar events or share news and announcements.